Dr. Treat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-214-1425
Education & Training
- Georgetown University HospitalFellowship, Medical Oncology, 1984
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1979 - 1982
- Lewis Katz School of Medicine at Temple UniversityClass of 1979
Certifications & Licensure
- PA State Medical License 1988 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC Start of enrollment: 2019 Sep 04
Publications & Presentations
PubMed
- 293 citationsPROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally A...Suresh Senan, Anthony Brade, Lu Hua Wang, Johan Vansteenkiste, Shaker R. Dakhil
Journal of Clinical Oncology. 2016-09-19 - 116 citationsPRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizu...Ralph Zinner, Coleman K. Obasaju, David R. Spigel, Robert W. Weaver, J. Thaddeus Beck
Journal of Thoracic Oncology. 2015-01-01 - 29 citationsHypersensitivity reactions from taxol and etoposide.David Friedland, Genevieve Gorman, Joseph Treat
Journal of the National Cancer Institute. 1993-12-01
Press Mentions
- Lantern Pharma Reports First Quarter 2024 Financial Results and Business HighlightsMay 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: